ISGSB2026
ISGSB 2026: The 22nd conference on International Study Group for Systems Biology
Abstract Submission — Invitation, Instructions and General Information
Invitation
ISGSB 2026 invites abstract submission. All submitted abstracts will be reviewed by experts in the field, and if approved, scheduled for either oral or poster presentations.
General Abstract Format Information
These details will be asked of you once you start the submission process. Please review this list before starting the submission process.
General required information and format restrictions
Abstract Title — 200 characters limit.
Authors and Affiliations:
- Identify all authors with full affiliation (institution, address and country), name, last name, email are required fields;
- Identification of the Presenting author (will receive an invitation email to upload presentation/poster a few weeks before the Congress);
- Identification of the Corresponding author (will receive all correspondence concerning submission).
Body of abstract — 3000 characters limit including spaces or 450 words, whichever is reached sooner.
Keywords (3-5)
Classification — Please use keywords that will help the reviewers to put your abstract in a suitable session. You can use as many as you need. Non-exclusive list of suggested topics: metabolic modeling, signalling, plant systems biology, theoretical systems biology, systems medicine, biotechnology, infrastructure, hybrid modeling, spatial modeling.
Additional requested information
Please indicate your preferred type of presentation:
- Either oral or poster presentation
- Poster presentation only (I do not wish to do an oral presentation)
- Oral presentation only (if my abstract is not accepted for oral presentation, I do not wish to present the abstract)
If selected for Poster, willingness to participate in interactive poster session:
- Yes
- No
Important notes to observe
Abstracts must be submitted in English.
Please check spelling and grammar carefully. All abstracts will be published as submitted.
Use generic names. Commercial drug names may not be used.
Abstract Limit: There are no restrictions on the number of abstracts you may submit and present, provided that each abstract represents distinct research.